Results

Total Results: 579 records

Showing results for "Grade D Cancer".

1. head-neck-cancer-update-140204 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_research-protocol.pdf
   February 04, 2014 - Cancer Network.2 The consensus definition of head and neck cancer includes tumors of: • larynx; … cancer; • esophageal cancer; and • trachea tumors. … [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB] OR tumours [TIAB] OR cancer [TIAB] OR cancers … "[Mesh] OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB … "[Mesh] OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [

2. Treatment of Stage I-III Squamous Cell Anal Cancer (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-protocol.pdf
   September 26, 2023 - Background Although anal cancer only represents1-2 percent of all gastrointestinal malignancies, incidence … D. … A., & American Joint Committee on Cancer Expert Panel on Cancers of the Lower Gastrointestinal, Anus … ti,ab. 28776 22 10 Neoplasm grading/ or Neoplasm Invasiveness/ or Neoplasm Metastasis/ or … Neoplasm Recurrence, Local/ or Recurrence/ or neoplasm staging/ or Tumor Burden/ or ((neoplasm?

3. Radiotherapy Treatments for Head and Neck Cancer: Update | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/head-neck-cancer-update/research-protocol
   February 04, 2014 - tumors otologic tumors cutaneous tumors of the head and neck (including melanoma) thyroid cancer … D. … OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB] OR tumours … "[Mesh] OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB … "[Mesh] OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB

4. Cancer-Pancreas Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
   September 01, 2014 - d. … d. … Testing for recurrent pancreatic cancer was excluded. d. … Studies that reported data by tumor (e.g., x percent of pancreatic adenocarcinoma tumors were correctly … Diagnostic management of pancreatic cancer. Cancers. 2011 Mar;3(1):494-509. 5.

5. Bladder-Cancer-Muscle-Invasive Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_executive.pdf
   June 01, 2015 - Approximately 25 percent of newly diagnosed bladder cancers present as stage 2 or higher tumors.5 Once … These include the stage of the cancer, tumor grade, whether the tumor is an initial tumor or a recurrence … d. … d. … and bladder–cancer- specific mortality appeared to be stronger for lower stage tumors than for higher

6. Renal-Cancer Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_executive.pdf
   February 01, 2016 - Given the increased incidence in early, low-stage tumors without improvement in cancer-related deaths … , histology, and grade)? … , and grade were inversely associated with cancer-specific survival. … Inclusion criteria varied among studies, and the relationship of age, tumor size, stage and grade to … Current composite models do not reliably predict malignancy; however, tumor size and male sex are most

7. Liver-Cancer-Therapy Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
   May 01, 2013 - Summary GRADE strength of evidence for KQ3 Key Question, Comparison, and Patient or Tumor Characteristics … Summary GRADE strength of evidence for KQ3 (continued) Key Question, Comparison, and Patient or Tumor … Authors varied in how these tumor characteristics were described: mean number and size of tumors, median … number and size of tumors, range of number and size of tumors, percent solitary and nonsolitary tumors … Hepatobiliary Cancers. Version 2. 2010.

8. Prostate-Cancer-Therapies-Update Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_executive.pdf
   December 01, 2014 - men of all ages, concluding that the harms of screening outweigh the benefits (Grade D recommendation … Current practice is to use tumor grade as the primary prognostic variable in patients with clinically … localized prostate cancer.2 After biopsy confirms the presence of the cancer, pathologists report tumor … grade using the Gleason score, which ranges from 2 to 10.4 Gleason 8 and higher tumors are considered … Owens DK, Lohr KN, Atkins D, et al.

9. Data Points 14: Use of Endocrine Therapy (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
   August 01, 2012 - With early inva- sive disease, use increased with increasing tumor size and declined with higher grade … Use was lowest among women with ER- tumors. Use did not vary greatly across tumor size or grade. … nd oc rin e t he ra py (% ) Tumor grade (differentiation) 3B. … Tumor Grade DCIS Early Invasive 0 25 50 75 100 Not Done Positive Negative Unknown Pa tie nt … With early invasive dis- ease, use increased with increasing tumor size and declined with higher grade

10. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
    October 01, 2015 - These include the stage of the cancer, tumor grade (higher grade tumors are more likely to recur and … progress), whether the tumor is an initial tumor or a recurrence, number and size of tumors, and patient … • Effects of tumor grade: Across urinary biomarkers, sensitivity increased with higher tumor grade … with higher tumor grade. … Stage, grade, tumor multiplicity, primary vs.

11. Organisation (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
    June 16, 2008 - Clinical Cancer Research 2006;12(7 Pt 1):2185-90. 16609033 D-1 Appendix D. … Journal Francais d Opthalmologie 1989;12(11):797-807. 2700992 No malignancy Zytkovicz A, Daftari … Uveal lymphoid neoplasia: a clinical-pathologic correlation and review of the early form. … Successful use of intracavitary bleomycin for low- grade astrocytoma tumor cyst. … EB, Muenter MW, Adams JA, et al. 3-D-conformal radiation therapy for pediatric giant cell tumors of

12. Surveillance & Identification of Triggers for Updating Systematic Reviews for the EHC Program (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_surveillance.pdf
    August 01, 2012 - A dosimetric correlation of radiation dose and early grade 3 dysphagia in oropharyngeal cancer patients … Fried D, Rosenman J, Varia M, et al. … or neoplasms or tumor or tumors or tumour or tumours or cancer or cancers or adenocarcinoma or carcinoma … or neoplasms or tumor or tumors or tumour or tumours or cancer or cancers or adenocarcinoma or carcinoma … or neoplasms or tumor or tumors or tumour or tumours or cancer or cancers or adenocarcinoma or carcinoma

13. Comparative Effectiveness of Fecal DNA Testing in Screening for Colorectal Cancer in Average-Risk Adults | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/colorectal-cancer-screening/research-protocol
    May 18, 2011 - For advanced neoplasia. … D. … Chou R, Aronson N, Atkins D et al. … Owens DK, Lohr KN, Atkins D et al. … Polyps/ 14 Colonic Neoplasms/ 15 Sigmoid Neoplasms/ 16 Rectal Neoplasms/ 17 Anus Neoplasms/ 18

14. Data Points 15: Breast Cancer Diagnostic Workup: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-prognostic-tests_research.pdf
    August 22, 2012 - We analyzed how testing varied by patient age, tumor size, and tumor grade—all factors known to increase … smaller tumors and higher grade tumors. … Tumors larger than 1 cm and high-grade tumors were associated with higher rates of HER2 testing except … Treatment targeted to ER+ tumors is very effective for women with invasive cancers and ER testing is … Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: Cancer J Clin 2012;62(1):10-29. 2.

15. Emerging Approaches to Diagnosis and Treatment of Non–Muscle-Invasive Bladder Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/bladder-cancer-non-muscle-invasive/research
    October 27, 2015 - of evidence [SOE]: moderate for quantitative nuclear matrix protein 22 [NMP22], qualitative bladder tumor … Sensitivity increased for higher stage and grade tumors. … Intravesical therapy appeared to be effective across subgroups defined by tumor stage, grade, multiplicity … difference between radiation therapy and no radiation therapy in clinical outcomes in patients with T1G3 cancers … Journal Publications Chou R, Gore JL, Buckley D, Fu R, Gustafson K, Griffin JC, et al.

16. Prostate-Cancer-Therapies-Update Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
    April 01, 2013 - in healthy men of all ages, concluding that the harms of screening outweigh the benefits (Grade D recommendation … grade in terms of the Gleason score, which ranges from 2 to 10.4 Gleason 8–10 tumors are considered … characteristics (prostate-specific antigen, tumor stage, histologic grade, tumor risk strata) Studies … EMBASE (EMTREE) Neoplasms/ Prostate/ Prostatic Neoplasms/ Cancer* Carcinoma* Neoplasm* Prostat … /radiotherapy”[mesh] 2 Prostate cancer “prostatic neoplasms”[mesh] OR (prostat*[tiab] AND (neoplasm*

17. Renal-Cancer Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
    April 20, 2015 - early-stage cancers, the death rate from kidney cancer has not changed significantly over the same … in the range of 0.55 to 0.65.[3, 16- 18] The best predictors of malignancy are male sex and tumor size … – who have the highest risk of having aggressive malignancies. … D. … ; 2) “moderate” grade; 3) “low” grade; and 4) “insufficient” grade.

18. Evidence-based Practice Center Systematic Review Protocol: Therapies for Clinically Localized Prostate Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
    November 02, 2019 - non-dermatologic malignancy (174,650 new cases) and the second leading cause of cancer death (31,620 … With AS, tumors are not immediately removed, irradiated, or ablated.3, 4 Instead, tumors are monitored … GRADE guidelines: 11. … / (121506) 2 (prostat* and (neoplasm* or cancer* or carcinoma*)).ti,ab. (142514) 3 watchful … / (9241) 2 (prostat$.ti,ab. or Prostate/) and (cancer.ti,ab. or Neoplasms/ or neoplasm$.mp. or

19. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies/protocol
    September 12, 2019 - non-dermatologic malignancy (174,650 new cases) and the second leading cause of cancer death (31,620 … With AS, tumors are not immediately removed, irradiated, or ablated. 3 , 4 Instead, tumors are monitored … GRADE guidelines: 11. … / (121506) 2     (prostat* and (neoplasm* or cancer* or carcinoma*)).ti,ab. (142514) 3     watchful … / (9241) 2     (prostat$.ti,ab. or Prostate/) and (cancer.ti,ab. or Neoplasms/ or neoplasm$.mp. or

20. Colorectal-Cancer-Staging Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_executive.pdf
    September 01, 2014 - Health care costs associated with care of these cancers is high, second only to breast cancer.3,4 … Disease characteristics (e.g., tumor grade)? iii. … Disease characteristics (e.g., tumor grade)? iii. … Disease characteristics (e.g., tumor grade)? iii. … Disease characteristics (e.g., tumor grade)? iii.